As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: SG Americas Securities LLC, Banque Pictet & Cie SA, Fortitude Family Office LLC, Halbert Hargrove Global Advisors LLC, Valeo Financial Advisors LLC, B. Riley Wealth Advisors Inc., Marex Group plc, Hudson Bay Capital Management LP, Wolverine Trading LLC, Nomura Holdings Inc., CTC LLC, National Bank of Canada FI, Select Equity Group L.P., Man Group plc, Modern Wealth Management LLC, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, 683 Capital Management LLC, Jane Street Group LLC, Quantinno Capital Management LP, HUB Investment Partners LLC, Volterra Technologies LP, Squarepoint Ops LLC, Alphadyne Asset Management LP, Diadema Partners LP, Qube Research & Technologies Ltd, B Group Inc., Maven Securities LTD, Capula Management Ltd, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Eisler Capital Management Ltd., MAI Capital Management, JPMorgan Chase & Co., Greenland Capital Management LP, Citigroup Inc., Persistent Asset Partners Ltd, Tortoise Investment Management LLC, Simplex Trading LLC, Bank of New York Mellon Corp, Mission Wealth Management LP, Wolverine Asset Management LLC, Allianz Asset Management GmbH, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.